Dr. Sofia J. Dasti, MD

Dr. Dasti practices at Robert Wood Johnson University Hospital Hamilton in Hamilton, New Jersey, part of RWJBarnabas Health.

Dr. Dasti's NPI, 1548207954, was assigned on June 2, 2006. Dr. Dasti holds New Jersey license 25MA06937200.

Dr. Dasti's primary practice is Robert Wood Johnson University Hospital Hamilton, at One Hamilton Health Place, Hamilton, NJ 08690 in Mercer County. The practice phone is (609) 586-7900. Dr. Dasti also practices at Robert Wood Johnson University Hospital - Hamilton, 1 Hamilton Health Pl, Trenton, NJ 08690.

Dr. Dasti's primary practice is Robert Wood Johnson University Hospital Hamilton in Hamilton, New Jersey, part of RWJBarnabas Health. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dr. Dasti to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dasti practices. Vendor and product names are available with a free account.

Emergency medicine is Dr. Dasti's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Dasti is licensed in New Jersey.

CMS data shows 708 Medicare services from Dr. Dasti across 6 procedure codes in 2024, for 528 Medicare patients. Medicare paid $64,454 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 528 Medicare patients who saw Dr. Dasti in 2024. The largest group is 75 to 84, with 172 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dasti's median patient age at 74, with 56% women.

In 2024, Dr. Dasti wrote 179 Medicare Part D claims for 133 patients. 98% of them were for generic drugs. CMS names the drug for 85 of them, across 5 drugs with 11 or more claims each, at $481 in total drug cost. In 2023, CMS named 80 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Dasti for performance year 2024, reported as part of a group. Dr. Dasti accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 15 general payments to Dr. Dasti from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $209.